SMSPHARMA — SMS Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹47.58bn
- IN₹50.69bn
- IN₹8.87bn
Annual cashflow statement for SMS Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 685 | 53.5 | 661 | 923 | 1,166 |
| Depreciation | |||||
| Non-Cash Items | 138 | 209 | 225 | 179 | 208 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -742 | -359 | -699 | -629 | -1,181 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 402 | 225 | 501 | 817 | 592 |
| Capital Expenditures | -272 | -299 | -522 | -1,234 | -1,306 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.944 | 1.65 | 0.88 | -0.491 | -2.22 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -272 | -298 | -521 | -1,234 | -1,308 |
| Financing Cash Flow Items | -138 | -209 | -218 | -174 | -221 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -69.2 | -320 | 307 | 471 | 760 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 61.6 | -393 | 287 | 53.6 | 44.8 |